AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
APIXABAN 2.5 Mg ;
14 registrations across 1 African market— 14 active
Markets with APIXABAN 2.5 Mg ;
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Apixaguard 2.5 mg Film Coated Tablets | 🇪🇬Egypt | Marcyrl pharmaceutical industries - MPI | active | — |
| Pixcolt Film Coated Tablets | 🇪🇬Egypt | Minapharm company for pharmaceuticals and chemical industries | active | — |
| Apixaguard 2.5 mg Film Coated Tablets | 🇪🇬Egypt | Marcyrl pharmaceutical industries - MPI | active | — |
| Apixalase 2.5 mg Film Coated Tablets | 🇪🇬Egypt | Multicare Egypt for Pharmaceutical Industries | active | — |
| Liptixaban 2.5mg Film Coated Tablets | 🇪🇬Egypt | Liptis for Pharmaceuticals and Medical Products | active | — |
| Apixaban - Alexandria co. for Pharmaceuticals and Chemical industries 2.5 mg Film Coated Tablets | 🇪🇬Egypt | Alexandria Co. For Pharmaceuticals and Chemical Industries | active | — |
| Pixcolt Film Coated Tablets | 🇪🇬Egypt | Minapharm company for pharmaceuticals and chemical industries | active | — |
| Liptixaban 2.5mg Film Coated Tablets | 🇪🇬Egypt | Liptis for Pharmaceuticals and Medical Products | active | — |
| Apixaban - Alexandria co. for Pharmaceuticals and Chemical industries 2.5 mg Film Coated Tablets | 🇪🇬Egypt | Alexandria Co. For Pharmaceuticals and Chemical Industries | active | — |
| Prevaxinal 2.5 mg Film Coated Tablets | 🇪🇬Egypt | D.B.K FOR PHARMACEUTICAL INDUSTRIES | active | — |
| Prevaxinal 2.5 mg Film Coated Tablets | 🇪🇬Egypt | D.B.K FOR PHARMACEUTICAL INDUSTRIES | active | — |
| Elimbosis 2.5mg Film Coated Tablets | 🇪🇬Egypt | Zeta Pharma for Pharmaceutical Industries (Zeta Pharma) | active | — |
| Apixaban-Chemipharm 2.5 mg Film Coated Tablets | 🇪🇬Egypt | Chemipharm Pharmaceutical Industries | active | — |
| Apixaned 2.5 mg Film Coated Tablets | 🇪🇬Egypt | ATM Pharmaceutical Industries, Import and Export | active | — |
APIXABAN 2.5 Mg ; in Africa — Regulatory Overview
APIXABAN 2.5 Mg ; is registered across 1 African markets with 14 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.
Of the 14 registrations, 14 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.